Glenn R. Cunningham

15.7k total citations · 4 hit papers
98 papers, 8.6k citations indexed

About

Glenn R. Cunningham is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Glenn R. Cunningham has authored 98 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Endocrinology, Diabetes and Metabolism, 28 papers in Molecular Biology and 23 papers in Reproductive Medicine. Recurrent topics in Glenn R. Cunningham's work include Hormonal and reproductive studies (68 papers), Sexual Differentiation and Disorders (22 papers) and Pharmacology and Obesity Treatment (18 papers). Glenn R. Cunningham is often cited by papers focused on Hormonal and reproductive studies (68 papers), Sexual Differentiation and Disorders (22 papers) and Pharmacology and Obesity Treatment (18 papers). Glenn R. Cunningham collaborates with scholars based in United States, United Kingdom and Italy. Glenn R. Cunningham's co-authors include Ronald S. Swerdloff, Alvin M. Matsumoto, Peter J. Snyder, Shalender Bhasin, Frances J. Hayes, Víctor M. Montori, Christina Wang, Adrian S. Dobs, Thomas J. Weber and Ali Iranmanesh and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Glenn R. Cunningham

97 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline

2010 1.4k citations Shalender Bhasin, Glenn R. Cunningham et al. The Journal of Clinical Endocrinology & Metabolism profile →
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline

2018 1.0k citations Shalender Bhasin, Juan P. Brito et al. The Journal of Clinical Endocrinology & Metabolism profile →
Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline

2006 711 citations Shalender Bhasin, Glenn R. Cunningham et al. The Journal of Clinical Endocrinology & Metabolism profile →
Transdermal Testosterone Gel Improves Sexual Function, Mood, Muscle Strength, and Body Composition Parameters in Hypogonadal Men1

2000 690 citations Ronald S. Swerdloff, Ali Iranmanesh et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Glenn R. Cunningham United States	39	6.2k	2.5k	2.1k	1.8k	1.2k	98	8.6k
Farid Saad Germany	52	6.3k 1.0×	1.7k 0.7×	2.8k 1.4×	1.3k 0.7×	1.4k 1.2×	169	7.9k
Shehzad Basaria United States	50	5.4k 0.9×	1.9k 0.7×	1.5k 0.7×	1.0k 0.6×	1.1k 0.9×	191	9.1k
Abdulmaged M. Traish United States	58	5.5k 0.9×	2.8k 1.1×	1.4k 0.7×	1.1k 0.6×	643 0.5×	213	10.1k
Frances J. Hayes United States	40	4.9k 0.8×	2.7k 1.1×	1.6k 0.8×	3.8k 2.1×	981 0.8×	80	8.2k
Giulia Rastrelli Italy	50	5.6k 0.9×	1.6k 0.6×	1.8k 0.8×	1.8k 1.0×	784 0.7×	212	8.1k
Shalender Bhasin United States	34	3.8k 0.6×	2.0k 0.8×	937 0.4×	954 0.5×	1.7k 1.4×	65	6.3k
A.W. Meikle United States	51	4.5k 0.7×	1.6k 0.7×	717 0.3×	1.5k 0.8×	497 0.4×	238	7.9k
Christopher Longcope United States	65	7.7k 1.2×	3.1k 1.2×	1.2k 0.6×	3.0k 1.7×	1.1k 1.0×	227	15.1k
A. Vermeulen Belgium	40	5.0k 0.8×	1.6k 0.6×	709 0.3×	2.2k 1.2×	768 0.6×	144	7.5k
Mathis Grossmann Australia	48	3.5k 0.6×	2.6k 1.0×	1.3k 0.6×	1.1k 0.6×	982 0.8×	198	8.8k

Countries citing papers authored by Glenn R. Cunningham

Since Specialization

Citations

This map shows the geographic impact of Glenn R. Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn R. Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn R. Cunningham more than expected).

Fields of papers citing papers by Glenn R. Cunningham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn R. Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn R. Cunningham. The network helps show where Glenn R. Cunningham may publish in the future.

Co-authorship network of co-authors of Glenn R. Cunningham

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn R. Cunningham. A scholar is included among the top collaborators of Glenn R. Cunningham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn R. Cunningham. Glenn R. Cunningham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhasin, Shalender, Juan P. Brito, Glenn R. Cunningham, et al.. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 103(5). 1715–1744. 1013 indexed citations breakdown →

Debruyne, F.M.J., Hermann M. Behre, Claus G. Roehrborn, et al.. (2016). Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men. British Journal of Urology. 119(2). 216–224. 59 indexed citations

Rosen, Raymond C., Alisa J. Stephens‐Shields, Glenn R. Cunningham, et al.. (2015). Comparison of interactive voice response (IVR) with paper administration of instruments to assess functional status, sexual function, and quality of life in elderly men. Quality of Life Research. 25(4). 811–821. 3 indexed citations

Cunningham, Glenn R.. (2014). Testosterone and metabolic syndrome. Asian Journal of Andrology. 17(2). 192–192. 42 indexed citations

Bhasin, Shalender, Glenn R. Cunningham, Frances J. Hayes, et al.. (2010). Testosterone therapy in men with androgen deficiency syndromes: An endocrine society clinical practice guideline (Journal of Clinical Endocrinology and Metabolism (2010) 95, (2536-2559)). The Journal of Clinical Endocrinology & Metabolism. 95(8). 115 indexed citations

Bhasin, Shalender, Glenn R. Cunningham, Frances J. Hayes, et al.. (2010). Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 95(6). 2536–2559. 1407 indexed citations breakdown →

Garcia, José M., Huiling Li, Douglas L. Mann, et al.. (2006). Hypogonadism in male patients with cancer. Cancer. 106(12). 2583–2591. 79 indexed citations

Saxena, Sunita, et al.. (2005). Critical Laboratory Value Notification: A Failure Mode Effects and Criticality Analysis. The Joint Commission Journal on Quality and Patient Safety. 31(9). 495–506. 19 indexed citations

Wang, Christina, Ronald S. Swerdloff, Ali Iranmanesh, et al.. (2001). Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clinical Endocrinology. 54(6). 739–750. 131 indexed citations

10.

Cunningham, Glenn R.. (2000). Management of male aging: which testosterone replacement therapy should be used?. The Aging Male. 3(4). 203–209. 6 indexed citations

11.

Marcelli, Marco, Glenn R. Cunningham, Sigmund J. Haidacher, et al.. (1998). Activation of caspase-3 and -7 during apoptosis of the human prostate cancer cell line LNCaP. 39. 577. 1 indexed citations

12.

Padayatty, Sebastian J., et al.. (1997). Lovastatin-Induced Apoptosis in Prostate Stromal Cells. The Journal of Clinical Endocrinology & Metabolism. 82(5). 1434–1439. 72 indexed citations

13.

Hirshkowitz, Max, et al.. (1997). Androgen and sleep-related erections. Journal of Psychosomatic Research. 42(6). 541–546. 40 indexed citations

14.

Cunningham, Glenn R., et al.. (1994). Effects of 4‐MAPC, a 5α‐reductase inhibitor, and cyproterone acetate on regrowth of the rat ventral prostate. The Prostate. 24(4). 212–220. 16 indexed citations

15.

Klima, Marcella, et al.. (1992). 4-MAPC, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight, DNA, and prostatein concentrations.. PubMed. 12(5). 315–22. 8 indexed citations

16.

Ghusn, Husam, et al.. (1991). 4‐MAPC, a 5α‐Reductase Inhibitor, Reduces Rat Ventral Prostate Weight, DNA, and Prostatein Concentrations. Journal of Andrology. 12(5). 315–322. 6 indexed citations

17.

Cunningham, Glenn R., et al.. (1990). Testosterone Replacement Therapy and Sleep-Related Erections in Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism. 70(3). 792–797. 100 indexed citations

18.

Young, Charles Y.F., et al.. (1990). Prostatein C₃‐mRNA: A sensitive marker of androgen‐responsiveness in prostate explant cultures. The Prostate. 17(1). 41–55. 9 indexed citations

19.

Cunningham, Glenn R., et al.. (1990). Abnormal growth hormone dynamics in chronic liver disease do not depend on severe parenchymal disease. Metabolism. 39(4). 349–356. 26 indexed citations

20.

Cunningham, Glenn R., et al.. (1981). Recovery from Severe Oligospermia After Exposure to Dibromochloropropane. Fertility and Sterility. 35(1). 46–53. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact